Prednisolone

Prednisolone

SCHEMBL1803463

C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO.O=S(=O)(O)O.[NaH]

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

NR3C1

The experimentally established mechanism targets of Prednisolone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 known ✓ P04150 10/20 0.91
▸ HIF1A Q16665 9/20 0.91
▸ HSD17B10 Q99714 8/20 0.91
▸ PGR P06401 5/20 0.91
▸ CYP3A4 P08684 4/20 0.91
▸ CYP2C19 P33261 3/20 0.91
▸ ABCB11 O95342 2/20 0.91
▸ SERPINA6 P08185 2/20 0.91
▸ NR3C2 P08235 2/20 0.91
▸ TNF P01375 1/20 0.91
▸ IL6 P05231 1/20 0.91
▸ AR P10275 1/20 0.91
▸ GLUL P15104 1/20 0.91
▸ ADAM17 P78536 1/20 0.91
▸ GPBAR1 Q8TDU6 1/20 0.91
▸ LMNA P02545 2/20 0.65
▸ ALDH1A1 P00352 2/20 0.65
▸ ABCC4 O15439 1/20 0.65
▸ NR1I2 O75469 1/20 0.65
▸ PDE4D Q08499 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Prednisolone SCHEMBL5524347 0.99 NR3C1 (0.93) NR3C1HIF1AHSD17B10PGRCYP3A4
Prednisolone SCHEMBL28451307 0.96 NR3C1 (0.91) NR3C1HIF1AHSD17B10PGRCYP3A4
Prednisolone SCHEMBL5073648 0.96 NR3C1 (0.98) NR3C1HIF1AHSD17B10PGRCYP3A4
Prednisolone SCHEMBL503432 0.96 NR3C1 (0.98) NR3C1HIF1AHSD17B10PGRCYP3A4
Prednisolone SCHEMBL503431 0.96 NR3C1 (0.98) NR3C1HIF1AHSD17B10PGRCYP3A4
Prednisolone SCHEMBL5073644 0.96 NR3C1 (0.98) NR3C1HIF1AHSD17B10PGRCYP3A4
Prednisolone SCHEMBL23863778 0.95 NR3C1 (1.00) NR3C1HIF1AHSD17B10PGRCYP3A4
Prednisolone SCHEMBL6566835 0.95 NR3C1 (1.00) NR3C1HIF1AHSD17B10PGRCYP3A4
Prednisolone SCHEMBL2597917 0.95 NR3C1 (1.00) NR3C1HIF1AHSD17B10PGRCYP3A4
Prednisolone SCHEMBL12396679 0.95 NR3C1 (1.00) NR3C1HIF1AHSD17B10PGRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11730697-B2 Ocular drug delivery devices BAUSCH HEALTH AMERICAS, INC. (US) 2023-08-22 — — US claimed
US-20190133934-A1 Ocular Drug Delivery Devices ATON PHARMA, INC. (BM) 2019-05-09 — — US claimed
EP-2493459-B1 OCULAR DRUG DELIVERY DEVICES ATON PHARMA INC (US) 2016-08-24 — — EP claimed
US-20140187497-A1 Ocular Drug Delivery Devices LOUISIANA STATE UNIVERSITY AGRICULTURAL AND MECHANICAL COLLEGE (US) 2014-07-03 — — US claimed
EP-2493459-A1 OCULAR DRUG DELIVERY DEVICES Aton Pharma, Inc. (US) 2012-09-05 — — EP claimed
US-20120213840-A1 OCULAR STRIPS VALEANT INTERNATIONAL (BARBADOS) SRL 2012-08-23 — — US claimed
US-20120215184-A1 CYLINDRICAL OCULAR INSERTS VALEANT INTERNATIONAL (BARBADOS) SRL 2012-08-23 — — US claimed
WO-2012112638-A1 CROSS REFERENCE TO RELATED APPLICATIONS VALEANT INTERNATIONAL (BARBADOS) SRL (BB) 2012-08-23 — — WO claimed
WO-2012112636-A1 CYLINDRICAL OCULAR INSERTS VALEANT INTERNATIONAL (BARBADOS) SRL (BB) 2012-08-23 — — WO claimed
US-20110129516-A1 OCULAR DRUG DELIVERY DEVICES ATON PHARMA, INC. 2011-06-02 — — US claimed
WO-2011053841-A1 OCULAR DRUG DELIVERY DEVICES ATON PHARMA, INC. (US) 2011-05-05 — — WO claimed
US-11730697-B2 Ocular drug delivery devices BAUSCH HEALTH AMERICAS, INC. (US) 2023-08-22 — — US disclosed
US-20190133934-A1 Ocular Drug Delivery Devices ATON PHARMA, INC. (BM) 2019-05-09 — — US disclosed
EP-2493459-B1 OCULAR DRUG DELIVERY DEVICES ATON PHARMA INC (US) 2016-08-24 — — EP disclosed
US-20140187497-A1 Ocular Drug Delivery Devices LOUISIANA STATE UNIVERSITY AGRICULTURAL AND MECHANICAL COLLEGE (US) 2014-07-03 — — US disclosed
WO-2002058672-A2 MICROPARTICLES OF BIODEGRADABLE POLYMER ENCAPSULATING A BIOLOGICALLY ACTIVE SUBSTANCE DEBIO RECHERCHE PHARMACEUTIQUE S.A. (CH) 2002-08-01 — — WO disclosed
WO-2002058671-A1 BURST FREE PHARMACEUTICAL MICROPARTICULES DEBIO RECHERCHE PHARMACEUTIQUE S.A. (CH) 2002-08-01 — — WO disclosed
EP-1196148-A1 PROCESS FOR MICROENCAPSULATION OF WATER SOLUBLE SUBSTANCES Debio Recherche Pharmaceutique S.A. (CH) 2002-04-17 — — EP disclosed
WO-2000062761-A1 PROCESS FOR MICROENCAPSULATION OF WATER SOLUBLE SUBSTANCES DEBIO RECHERCHE PHARMACEUTIQUE S.A. (CH) 2000-10-26 — — WO disclosed
EP-1044683-A1 One-step dispersion method for the microencapsulation of water soluble substances DEBIO RECHERCHE PHARMACEUTIQUE S.A. (CH) 2000-10-18 — — EP disclosed
Send feedback